Revolution Medicines, Inc.
SEC CIK 1628171 · RVMD · last insider filing 2026-06-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Borisy Alexis | Director | filed 2020 - 2026 |
| Horning Sandra | Director | filed 2023 - 2026 |
| Kim Lorence H. | Director | filed 2022 - 2026 |
| Anderson Elizabeth M | Director | filed 2020 - 2026 |
| Clyburn Frank | Director | filed 2024 - 2026 |
| Patel Sushil | Director | filed 2022 - 2026 |
| Borellini Flavia | Director | filed 2021 - 2026 |
| Goldsmith Mark A | Director · See Remarks | filed 2020 - 2026 |
| Schroeder Thilo | Director | filed 2020 - 2024 |
| Weber Barbara | Director | filed 2020 - 2024 |
| Schmidt Eric Thomas | Director | filed 2020 - 2023 |
| Exter Neil | Director | filed 2020 - 2022 |
| Miller Vincent A. | Director | filed 2020 - 2021 |
| Svennilson Peter | Director | filed 2020 - 2021 |
| Lasky Laurence | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Anders Jack | See Remarks | filed 2020 - 2026 |
| Kelsey Stephen Michael | See Remarks | filed 2020 - 2026 |
| Cislini Jeff | General Counsel | filed 2023 - 2026 |
| Mancini Anthony | See Remarks | filed 2026 - 2026 |
| Horn Margaret A | See Remarks | filed 2020 - 2026 |
| Sandler Alan B. | Chief Development Officer | filed 2026 - 2026 |
| Wang Xiaolin | See Remarks | filed 2021 - 2026 |
| Wei Lin | Chief Medical Officer | filed 2024 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.